选择性环氧化酶-2抑制剂在宫颈癌治疗中的应用研究进展
Progress of the study on selective COX-2 inhibitors in the treatment of uterine cervix cancer
出处
《武警医学院学报》
CAS
2008年第10期918-920,共3页
Acta Academiae Medicinae CPAPF
参考文献27
-
1Telliez A, Furman C. Mechanisms leading to cox-2 expression and cox-2 induced tumor igenesis [J]. Anticancer Agents Med Chem, 2006, 16 (3): 187-208.
-
2Chen YJ, Wang LS, Wang PH, et al. High cyclooxygenase-2 expression in cervical adenocarcinomas [J]. Gynecol Oncol, 2003, 88 (3): 379-385.
-
3Kim HJ, Wu HG, Park IA, et al. High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2003, 55, (1): 16-20.
-
4Kim YB, Kim GE, Pyo HR, et al. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix [J]. Int J Radiat Oncol Biol Phys, 2004, 60 (3): 822 - 829.
-
5Lim JW, Kim H, Kim KH. Expression of Ku70 and Ku80 mediated by NF-kappa B and eyelooxygenase-2 is related to proliferation of human gastrie eaneer eells [J]. J Biol Chem, 2002, 277 (48):46093 - 46100.
-
6Raju U, Nakata E, Yang P, et al. In intro enhancement of tumor cell radiosensitivity by a selective inhibitor of cycolooxygenase-2 enzyme mechanistic considerations [ J ]. Int J Radiat Oncol Biol Phys, 2002, 54 (3): 886-894.
-
7Raju U, Ariga H, Ditmann K, et al. Inhibition of DAN repair as a mechanism of enehaneed radio response of head and neck carcinoma cells by a selective eyelooxygenase-2 inhibitor, eelecoxib [J]. Int J Radiat Oneol Biol Phys, 2005, 63: 520-528.
-
8Nakata E, Mason KA, Hunter N, et al. Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors [J]. Int J Radiat Oncol Biol Plays, 2004, 58 (2) : 369 - 375.
-
9Crokart N, Kim R, Benediete F, et al. Tumor radiosensitization by anti-inflammatory drugs: Evidence for a new mechanism involvingthe oxygen effect [J]. Cancer Res, 2005, 65 (Supp 11): 7911 - 7916.
-
10Pyo H, Choy H, Amorino CP, et al. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2 [J]. Clin Cancer Res, 2001, 7: 2998-3005.
二级参考文献37
-
1Wei Wang~1 Shu-Kui Qin~1 Bao-An Chen~2 Hui-Ying Chen~1 1 Chinese PLA Cancer Center,Chinese PLA 81 Hospital,Nanjing 210002,Jiangshu Province,China2 Affliliated Zhongda Hospital of Southeast University Medical College,Nanjing 210087,Jiangsu Province,China.Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma[J].World Journal of Gastroenterology,2001,7(5):702-705. 被引量:50
-
2Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and anti-tumor activities of cyclooxygenase-2 inhibitors[J]. Cancer Res, 2000,60(5): 1306-1311.
-
3Leahy KM, Ornberg RL, Wang Y, et al. Cyclooxygenase-2inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cell in vivo[J]. Cancer Res,2002,62(3) :625-631.
-
4Milas L, Furuta Y, Hunter N, et al. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence[J]. Cancer Res, 1990, 50 (16):4473-4477.
-
5Furuta Y, Elizabeth RH, Sanduja S, et al. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin[J]. Cancer Res, 1988, 48(13):3002-3007.
-
6Williams CS, Watson AJ, Sheng H, et al. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models[J]. Cancer Res,2000, 60(21) :6045-6051.
-
7Zhang L, Yu J, Park BA, et al. Role of BAX in the apoptotic response to anticancer agents [J]. Science, 2000, 290 (5439):989-992.
-
8Wu GD. A nuclear receptor to prevent colon cancer[J]. N Engl J Med,2000, 342(9) :651-653.
-
9Xiao-Chun Xu. COX-2 inhibitor in cancer treatment and prevention, a recent development[J]. Anti-caner drugs,2002, 13(2): 127-137.
-
10Kazushi K, Sven P, Cordula P, et al. Preferential enhance ment of tumor radioresponse by a cyclooxygenase-2 inhibitor[J]. Cancer Res,2000,60(5): 1326-1331.
共引文献7
-
1高岿然,史铁梅,邸晶,林琳,孙杰.宫颈癌移植瘤大鼠动物模型的建立[J].中国组织工程研究与临床康复,2008,12(28):5494-5498. 被引量:7
-
2阿地力江.伊明,姚明,葛海良,张惠珍,拉莱.苏祖克.C225单用及与DDP联用对子宫颈癌裸鼠移植瘤生长的影响[J].复旦学报(医学版),2008,35(4):579-584. 被引量:1
-
3丁翔,严春寅,浦金贤,王功成,侯建全,王利利,温端改,黄玉华.选择性环氧化酶-2抑制剂联合放疗对人前列腺癌裸鼠移植瘤作用的实验研究[J].苏州大学学报(医学版),2009,29(4):614-617. 被引量:3
-
4冯仕庭,孙灿辉,蔡华崧,周健,谭国胜,邱鹏新,张健,李子平,孟悛非.建立荷人结肠癌裸鼠移植瘤模型及MRI成像检查[J].中国组织工程研究与临床康复,2010,14(20):3696-3700. 被引量:7
-
5廖云志.肿瘤放疗增敏研究进展[J].亚太传统医药,2012,8(4):185-186. 被引量:2
-
6侯柏龙,杜王琪,熊一融,蔡一奇,宋易玲,林晓云,薛向阳,张丽芳.人宫颈癌SiHa细胞荷瘤裸鼠模型的建立及鉴定[J].温州医科大学学报,2016,46(2):92-96. 被引量:6
-
7吕开绩,张丽芳,卢叶挺,王高卿,周新华.CEA阳性细胞系的鉴定及其荷瘤小鼠模型建立[J].现代实用医学,2021,33(11):1408-1410.
-
1布拉盖,董梅.阴道镜检查480例分析[J].中国保健营养(临床医学学刊),2010,19(7):77-78.
-
2宋欢欢.腹腔镜下广泛子宫全切除+盆腔淋巴结清扫术与传统开腹手术在宫颈癌治疗中的比较[J].社区医学杂志,2012,10(5):8-9. 被引量:6
-
3黄家珍.非脱垂子宫经阴道切除25例临床分析[J].广西医学,2002,24(6):912-913.
-
4张建鸿.甲氨蝶呤、米非司酮对异位妊娠保守治疗的研究[J].实用预防医学,2007,14(3):810-811. 被引量:12
-
5冷有旭.腹腔镜手术在早期宫颈癌治疗中的应用效果观察[J].中国继续医学教育,2015,7(23):127-128. 被引量:2
-
6雷慧,王建军,童晓文.宫颈癌中新辅助化疗的意义[J].外科研究与新技术,2013,2(3):189-192. 被引量:2
-
7邹烨,陈梅.腹腔镜手术治疗良性卵巢肿瘤84例临床分析[J].右江医学,2007,35(1):72-73.
-
8杨纪实,周留林,王倩.腹腔镜超声刀在早期宫颈癌治疗中的应用价值[J].华北煤炭医学院学报,2010,12(6):847-849. 被引量:1
-
9郭影,闫晓娟,庞义存,杜建层.COX-2和VEGF在宫颈病变中的表达[J].中国妇幼保健,2006,21(5):688-689. 被引量:9
-
10曾美.宫颈冷刀锥切在宫颈上皮内瘤变及早期宫颈癌中的应用价值[J].医药论坛杂志,2015,36(9):63-64. 被引量:4